Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Open-Label, Extension Study of NS-089/NCNP-02 in Patients With Duchenne Muscular Dystrophy

NCT05135663 is registered in ClinicalTrials.gov with Nippon Shinyaku Co., Ltd. as lead sponsor.

NCT NCT05135663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05135663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Open-Label, Extension Study of NS-089/NCNP-02 in Patients With Duchenne Muscular Dystrophy
Lead sponsor
Nippon Shinyaku Co., Ltd.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 23, 2021
Completion date
April 30, 2027
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy (dmd)